7pluscoin

7pluscoin

@trinurtrii

About Yeh Group

Yeh Group is the holding company of Penn Asia with a paid-up capital of 500 million Baht a warp knitting business with its dyeing and finishing. The company is located in Thailand, the heart of Southeast Asia, only 35 km west of Bangkok. Yeh Group produces functional fabrics (intimate wear and sportswear) for the global market. The company mainly produces nylon and spandex yarn, although spandex polyester is gaining popularity as a stiff fabric. Yeh Group has worked with leading regional brands for underwear and sportswear for more than 25 years.


Penn Asia has around 350 employees, while Yeh Group has around 1000 employees. Due to the outbreak of the COVID-19 pandemic, Yeh Group has paid more attention to the production of new textile materials which are highly protective with biological and chemical protection. These include new dry dye innovations and printing of microfiber face masks for medical and everyday use.


The global blockchain technology market volume is estimated to reach USD 1,590.9 million in 2018 and is expected to grow at a CAGR of 69.4% between 2019 and 2025. Blockchain technology is one of the most promising future technology trends in information technology. This allows for a ledger that is accessible to the parties involved in the transaction and can act as an undeniable universal repository for all transactions between the parties involved.


Yeh Group is developing a digital asset called 7PLUS COIN (7SVN COIN) which will serve as a utility token to facilitate the transaction and traceability of COVID-19 medical textiles.


The COVID-19 pandemic outbreak has exposed flaws in the health supply chain process. 7PLUS COIN is designed to improve health care supply chain management and tracking process of COVID-19 medical textiles such as face masks, gloves.


Over the years, Yeh Group has built a reputation for entrepreneurial innovation through initial investment in digital printing, creation of strategic tailoring and lamination partners, and the opening of the industry's first CO2 dyeing plant that allows polyester fabrics to be dyed unnecessarily. for coloring. any water use. Today, Dreydy technology supplies more than 10 million m2 of eco-friendly dyed fabrics.





Problems & Solutions

1. Poor management and tracking of health and pharmaceutical supply chains


This is a huge problem during the heat of the coronavirus pandemic. Government agencies find it very difficult to track the volume and location of important supplies. It has had a devastating effect on containing the spread of the virus and protecting the population.


Solution


The supply chains that support blockchain enable unchanging, transparent and efficient tracking of medical supplies from the point of production to the consumer. Throughout the supply chain, blockchain helps provide information, transparency, evidence, accuracy. with this information, the risks associated with the supply chain will be a minimum for all parties; inclusive producers and consumers.


2. Lack of confidence and public panic


When it became known that face masks from China to Europe (UK, China, Ireland, etc.) had been contaminated, it caused panic among the population. Public panic will do more harm than good as we try to contain the outbreak of this pandemic.


Solution


A blockchain system that securely tracks and verifies materials, production volume, availability, and quality will significantly increase public confidence in ingredients and even medicines. The blockchain system will allow fact-based information sharing. Tracing the origin and end point of medical textile materials will reduce unnecessary exposure and legal risks.


3. Lack of payment facilities


Traditionally, cross-border payments have been accompanied by high banking fees and time delays due to physical distance. This is really not helping the fight to combat the spread of the coronavirus pandemic. Delays in processing transactions hinder the timely transport of medical textile materials to the places they are needed. In addition, large multinational companies find it difficult to track many business transactions and accounts financially.


Solution


To address the lack of ease of payment in the COVID-19 medical supply kit supply chain, one can adopt a digital asset payment system to make it easier for producers and buyers. A great example of such a digital asset is the 7PLUS COIN created by the Yeh Group company.


4. Fake products


The counterfeit drug market is worth $ 75 billion annually, including supplies of medical textiles. On July 24, 2020, INTERPOL reported a global seizure of counterfeit medical products related to Covid-19. Items seized included 34,000 fake and substandard face masks. At a time when supplies of standard medical textiles are essential, we cannot allow a proliferation of counterfeit goods to enter the global market.


Solution


With the decentralized and immutable logging features that blockchain offers, we are able to track each COVID-19 textile medical supply journey to verify its authenticity or deficiency.

Trading on the Bitenium platform is the best and only cryptocurrency exchange built on the basis of machine learning and A1 trading.

To thrive in a crash-dependent crypto industry and stand tall, you need to take advantage of acceleration.

Correcting fashion trends, increasing disposable income and changing consumer lifestyles and preferences are expected to drive market growth. A growing concern about the fabrics used to make underwear is one of the main factors driving the market. The availability of products in a variety of fabrics such as cotton, polyester, nylon, rayon, silk and cotton blends drives product demand. Manufacturers focus on the design and pattern of intimate products such as laces, C-strings, tangas and bandages, among others, to serve a wider consumer base.


Token Allocation

image.png


7PLUS COIN was developed to enhance and promote seamless transactions between Yeh Group companies and tens of hundreds of future medical companies

around the world. The companies range from leading pharmaceutical companies such as US WorldMeds, Elorac Inc., Pacira Pharmaceuticals, Inc., Putney / Dechra, Clinipace

Around the world and many others.

7PLUS Coin is an ERC-20 utility token built on the Ethereum blockchain. It has a total supply of 200 million tokens, and costs $ 0.1 per SV7 coin each during private and public sales.

The token symbol, represented as SV7 has the following allocations:

7plus Token Sale

image.png


The token sale will be in batches and will take place simultaneously with several marketing auctions. It will follow a two-round token sale offering period to allow investors at various stages to contribute to the token sale. The total supply token is 200,000,000, and the price per token is $ 0.1. The total funds expected to be raised are $ 20 million. The first sale will be held from 12 February 2021 to 28 February 2021. Those who buy within this period will receive a 25% bonus on their purchases. The second phase of the sale will take place between April 1, 2021 and May 31, 2021. People who buy in the first two weeks of the sale will receive a 15% bonus. If you buy within 3-4 weeks of the sale, you will receive a 10% bonus. Also, those who buy within 5-8 weeks will receive a 5% bonus. All sales will end on May 31, 2021.

Budget allocation

image.png


Roadmap


Jan 2020

Introducing and launching the 7PLUS Brand to domestic and international markets. Authentic token and native L2L token based on the development of an economic model at ERC20


Feb 2021:

Official project announcement. White paper releases and various social media platforms. Open to the public for Presale, Private sale and soft cap via IEO on the Bitenium exchange.


Apr. - May 2021:

7PLUS opens the public through retail and e-commerce outlets. Start and offer 7PLUSCOIN hard cap and distribution to investors


K4 2021:

Register on Coinmarketcap.com. 7PLUSCOIN is open for public trading on the Bitenium exchange. Develop supply chain software for Drydye and our medical textiles and the more international 7PLUS retail outlet.


K1 2022:

Road show and introduction to the expert team behind 7PLUS. Showcase the latest solutions and benefits of sportswear, underwear and medical textiles with Drydye technology.


Q3 2022: Q3 2023

Buy back and burn 20% of 7PLUSCOIN. The total repurchase will be 40%. The remaining tokens will circulate on the stock market.


Our team

  • Jimmy Yeh - President
  • Chareeporn Yeh - Vice President
  • Negel Pages - CMO Sales & Marketing
  • Prathya Thanasomboon - Administrasi CPO
  • Sorin Mic - Operations Director
  • David Round - Director of Innovation
  • X 10 Agency - Bounty, Marketing & Community Management

Advisor

Medical Advisor

Dr.  CHITTIWAT SUPRASONGSIN


Blockchain Consultant Advisor

Dusit madan

Kanjana Wattanavichean

Chanin Torut


For more detailed information, please contact the link below:

Author:

trinurtrii

https://bitcointalk.org/index.php?action=profile;u=1238810

0x44407B1662a5751Fc486866e42254008B9eE9262



Report Page